BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12508384)

  • 1. Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission.
    Katrib A; Smith MD; Ahern MJ; Slavotinek J; Stafford L; Cuello C; Bertouch JV; McNeil HP; Youssef PP
    J Rheumatol; 2003 Jan; 30(1):10-21. PubMed ID: 12508384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study.
    Young L; Katrib A; Cuello C; Vollmer-Conna U; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    Arthritis Rheum; 2001 Feb; 44(2):343-50. PubMed ID: 11229465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis.
    Katrib A; Tak PP; Bertouch JV; Cuello C; McNeil HP; Smeets TJ; Kraan MC; Youssef PP
    Rheumatology (Oxford); 2001 Sep; 40(9):988-94. PubMed ID: 11561108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis.
    Wong P; Cuello C; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    Rheumatology (Oxford); 2000 Oct; 39(10):1067-73. PubMed ID: 11035124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.
    Yoshida W; Uzuki M; Nishida J; Shimamura T; Sawai T
    Clin Exp Rheumatol; 2009; 27(4):587-93. PubMed ID: 19772789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
    O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
    Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
    Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
    Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
    Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pulse methylprednisolone on macrophage chemotactic protein-1 and macrophage inflammatory protein-1alpha in rheumatoid synovium.
    Wong PK; Cuello C; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    J Rheumatol; 2001 Dec; 28(12):2634-6. PubMed ID: 11764208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.
    Catrina AI; Lampa J; Ernestam S; af Klint E; Bratt J; Klareskog L; Ulfgren AK
    Rheumatology (Oxford); 2002 May; 41(5):484-9. PubMed ID: 12011369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.
    Kane D; Jensen LE; Grehan S; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2004 Jul; 31(7):1274-80. PubMed ID: 15229943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet's disease and familial Mediterranean fever?
    Pay S; Erdem H; Serdar M; Dinç A; Simşek I; Turan M
    Clin Rheumatol; 2002 Nov; 21(6):511-5. PubMed ID: 12447637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
    Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
    Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.